Related Experiment Video
Updated: Oct 3, 2025

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
Published on: September 17, 2012
Quantitative profiling of adaptation to cyclin E overproduction.
Juanita C Limas1, Amiee N Littlejohn2, Amy M House2
1Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Cells adapt to toxic cyclin E overproduction by down-regulating G1 genes, showing non-genetic adaptation. This reveals how cancer cells tolerate oncogene overexpression and CDK regulation of DNA replication.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Cyclin E/CDK2 complex regulates G1 to S phase cell cycle transition.
- Cyclin E gene overexpression is observed in various cancers, despite its toxicity.
- Understanding cellular tolerance to cyclin E overexpression is crucial for cancer biology.
Purpose of the Study:
- To investigate how non-transformed epithelial cells tolerate chronic cyclin E overproduction.
- To elucidate the mechanisms underlying cellular adaptation to oncogene overexpression.
- To explore the relationship between cyclin E/CDK activity and DNA replication licensing.
Main Methods:
- Chronic cyclin E overproduction in non-transformed epithelial cells.
- Analysis of cell cycle dynamics, CDK activity, and DNA replication.
- Transcriptome analysis to identify gene expression changes.
- Assessment of adaptation reversibility upon cyclin E withdrawal.
Main Results:
- Cells overproducing cyclin E exhibited truncated G1 phases, replication stress, and impaired proliferation.
- Significant intercellular heterogeneity in cell cycle dynamics and CDK activity was observed.
- Adapted cells showed down-regulation of G1-regulated genes and partial resistance to cyclin E withdrawal.
- Evidence suggests cyclin E/CDK inhibits origin licensing indirectly via premature S phase onset.
Conclusions:
- Mammalian cells can adapt to chronic cyclin E overproduction through both genetic and non-genetic mechanisms.
- Cyclin E/CDK plays an inhibitory role in origin licensing, mediated by premature S phase entry.
- This study offers insights into oncogene adaptation, potentially mirroring tumorigenesis processes.
Related Concept Videos
Positive Regulator Molecules
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
Anaphase Promoting Complex
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

